Trials / Terminated
TerminatedNCT02881554
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
Functional Liver Imaging With Sulfur Colloid SPECT/CT in Primary and Metastatic Liver Cancer Patients Receiving Liver-Directed Treatment: A Pilot Study
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- University of Washington · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This pilot trial studies how well single photon emission computed tomography (SPECT)/computed tomography (CT) with technetium Tc-99m sulfur colloid works in measuring liver function in patients with liver cancer that has or has not spread to other place in the body who are undergoing radiation therapy or surgery. Diagnostic procedures, such as sulfur colloid SPECT/CT scans, may measure normal liver tissue before, during and after treatment and help doctors plan better treatment for liver cancer patients.
Detailed description
OUTLINE: Patients are assigned to 1 of 2 cohorts depending on which standard of care they are receiving outside of this study, as part of their cancer treatment: radiation treatment (RT) or surgery. All patients have a total of 3 SPECT/CT imaging with 99mTc-SC. The first scan in both cohorts is routine medical care (not experimental) and takes place prior to initiation of RT or surgery. Two follow up scans are part of the protocol. COHORT A (patients receiving radiation therapy per standard cancer treatment): The first follow up scan occurs at mid-RT, and the second one at 1 month post-RT. COHORT B (patients undergoing surgery per standard cancer treatment): The first follow-up scan occurs 3-5 days postoperatively, and the second one at 1 month post-operatively. An additional intravenous (IV) contrast enhanced CT scan (70 second delay) will be obtained immediately following the SPECT/CT scan for all 3 SPECT/CT scans. After completion of study, patients are followed up at 6 months.
Conditions
- Hepatocellular Carcinoma
- Intrahepatic Cholangiocarcinoma
- Stage IV Liver Cancer
- Stage IVA Liver Cancer
- Stage IVB Liver Cancer
- Vascular Thrombosis
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Computed Tomography | Undergo SC SPECT/CT |
| PROCEDURE | Single Photon Emission Computed Tomography | Undergo SC SPECT/CT |
| DRUG | Technetium Tc-99m Sulfur Colloid | Given IV |
Timeline
- Start date
- 2016-12-21
- Primary completion
- 2024-07-31
- Completion
- 2025-02-09
- First posted
- 2016-08-29
- Last updated
- 2025-10-29
- Results posted
- 2025-10-29
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02881554. Inclusion in this directory is not an endorsement.